The A' Cybernetics, Prosthesis and Implant Design Award has announced its comprehensive prize package for the 2024-2025 competition period, offering an extensive array of benefits designed to celebrate and promote excellence in cybernetics innovation.
The FamilieSCN2A Foundation, the leading nonprofit organization in the world dedicated to improving the lives of individuals affected by SCN2A-related disorders (SRDs), is proud to announce a strategic partnership with Cellectricon, a cutting-edge biotechnology company specializing in advanced neuronal assay technologies.
FOR IMMEDIATE RELEASE Collaboration Integrates Kineviz’s GraphXR Platform and SightXR AI with Ultipa Powerhouse, the Next-Generation Graph Platform, to Unlock Complex Data Relationships and Real-Time Graph Analytics Ultipa, Inc.
The FamilieSCN2A is excited to announce a new partnership with Children’s Hospital Colorado Neurogenetics Clinic to expand multidisciplinary care in SCN2A-related disorders (SRDs).
Memphasys Limited (ASX:MEM) (FRA:IG7) is pleased to announce successful completion of the data lock for the pivotal Felix(TM) clinical trial. This marks a critical milestone in ensuring the accuracy and integrity of the trial data.
Netstar Lifestyle Magazine is an online magazine website on Australian lifestyle matters, travel and fashion for the discerning blog reader on the web.
A surge in the number of minimally invasive surgeries and the rise in the prevalence of chronic diseases such as endometrial cancer, bladder cancer, and gastrointestinal diseases which causes an increase in the application & usage of fluid management devices drives the global fluid management devices market.
